# Services from clinicalintelpulse.vercel.app on Zero

> clinicalintelpulse.vercel.app serves 10 paid API services for AI agents, indexed by Zero. Each is callable per call with payment handled by Zero.

Canonical page: https://www.zero.xyz/host/clinicalintelpulse.vercel.app
Live health (JSON, refreshed every minute): https://www.zero.xyz/host/clinicalintelpulse.vercel.app/health.json

## Services

- [ClinicalIntelPulse Patient Trial Finder](https://www.zero.xyz/c/clinicalintelpulse-patient-trial-finder-2ca14863/llms.txt): $0.1/call via x402. Finds actively recruiting clinical trials for a disease with plain-language summaries, accessible eligibility criteria, contact info, and application guidance drawn from 400,000+ ClinicalTrials.gov studies
- [ClinicalIntelPulse Pipeline Scan](https://www.zero.xyz/c/clinicalintelpulse-pipeline-scan-88bf5074/llms.txt): $0.15/call via x402. Returns a broad-sweep analysis of all active Phase 2/3 clinical trials for any disease worldwide, including trial count, sponsor landscape, geographic distribution, and pipeline density across 400,000+ trials.
- [ClinicalIntelpulse Clinical Trial Failure Analysis](https://www.zero.xyz/c/clinicalintelpulse-clinical-trial-failure-analysis-a8f36e8f/llms.txt): $0.2/call via x402. Returns historical Phase 2/3 failure mode analysis for a disease area, covering patient selection, endpoint design, mechanism, dosing, and safety failures with phase transition success rates.
- [ClinicalIntelPulse Sponsor Intel](https://www.zero.xyz/c/clinicalintelpulse-sponsor-intel-9c6649b2/llms.txt): $0.2/call via x402. Full pipeline analysis for a pharma or biotech company — trial counts by phase, therapeutic-area coverage, FDA history, partnerships, and competitive positioning.
- [ClinicalIntelPulse Trial Brief](https://www.zero.xyz/c/clinicalintelpulse-trial-brief-af03bfc8/llms.txt): $0.1/call via x402. Returns a comprehensive deep-dive on a specific clinical trial by NCT ID, including full study design, endpoints, enrollment status, sponsor, eligibility criteria, and publications.
- [ClinicalIntelPulse Mechanism Map](https://www.zero.xyz/c/clinicalintelpulse-mechanism-map-9845f981/llms.txt): $0.2/call via x402. Returns the molecular target and mechanism-of-action landscape for a disease, including targets in active trials, approved agents by MOA, crowded vs. novel spaces, and first-in-class openings.
- [ClinicalIntelPulse Disease Landscape](https://www.zero.xyz/c/clinicalintelpulse-disease-landscape-3e5cf534/llms.txt): $0.35/call via x402. Returns a complete pipeline intelligence snapshot for any disease area, covering Phase 2-3 trial map, mechanism coverage, approved therapies, PDUFA calendar, competitive gaps, and market dynamics.
- [ClinicalIntelPulse Global Trial Landscape](https://www.zero.xyz/c/clinicalintelpulse-global-trial-landscape-16a0c199/llms.txt): $0.15/call via x402. Returns international clinical trial geographic distribution across WHO ICTRP registries (US, EU, China, India, Japan, Brazil and more), highlighting access gaps and unmet need for any disease area
- [ClinicalIntelPulse FDA/EMA Approval Outlook](https://www.zero.xyz/c/clinicalintelpulse-fda-ema-approval-outlook-be1afa8d/llms.txt): $0.25/call via x402. Analyzes FDA/EMA approval probability for drugs in a given disease area, ranking candidates most likely to win approval in 12–18 months based on Phase 3 data, PDUFA dates, and historical trial success rates.
- [ClinicalIntelPulse Deal Signal — M&A & Licensing Intelligence for Clinical Assets](https://www.zero.xyz/c/clinicalintelpulse-deal-signal-m-a-licensing-intelligence-for-b307d08c/llms.txt): $0.35/call via x402. Returns M&A and licensing deal signals for Phase 2/3 clinical assets, including acquisition probability scores, deal comps, and transaction multiples for a given disease or asset.

Status and success rate cover calls made through Zero and Zero's own probes. Third-party monitors may report differently.

- [Zero catalog index](https://www.zero.xyz/llms.txt)